Professor Giuseppe Rosano discusses "True advances in the treatment of heart failure" at the 2015 ESC congress in London.

Questions:

1. In your view, what are the true advances in the management of heart failure?
2. Of the new therapeutic agents, which, in your view, are more likely to make a difference in terms of survival and hospitalisations?
3. Do oestrogen and testosterone play any role in the management of angina pectoris? And what is the evidence?